BioSpace News Archive

Forlenza brings over 40 years of experience in leadership roles at BD, a $70B market cap medical technology market leader, and will bring a wealth of knowledge in commercialization, scaling healthcare businesses, and improving patient outcomes

NantKwest Executive Chairman Dr. Patrick Soon-Shiong to Present at 39 th Annual J.P. Morgan Healthcare Conference on January 13, 2021

Alegeus, the market leader in consumer-directed healthcare (CDH) solutions, has welcomed three new members to its executive leadership team over the past several months: Leif O’Leary as Chief Executive Officer, Shay Gonen as Chief Financial Officer, and Aditya Joshi (AJ) as Chief Product and Technology Officer. O’Leary, Gonen and Joshi will join the

Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced today a partnership to identify and develop novel small molecules for the treatment of neurological disorders.

601 Congress Street further builds on developer’s premier life science real estate portfolio in Boston/Cambridge

CSafe Global, a leading provider of cold chain shipping solutions to global pharmaceutical and life sciences companies, and portfolio Company of Thomas H. Lee Partners, L.P., has completed the sale of a 50% stake to Frazier Healthcare Partners.

Charleston County Medical Society announced that ActionPPE, its collective buying initiative created by doctors for doctors, has shipped over 3.4 million units of personal protective equipment, including masks, respirators, gloves, gowns, face shields, and sanitizer, to 2,606 practices representing over 10,000 doctors.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has obtained a second U.S. Utility patent for its Blood Volume Monitor Device

Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced that it has earned ISO 9001:2015 certification for its quality management system and the ISO/IEC 27001:2013 certification for its systems and processes for managing sensitive company informatio

Boundless Bio to Present at the 39 th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect 2021 Conference